Mark J Enyedy's Net Worth
$52.4 Million
Who is Mark J Enyedy?
Mark J Enyedy has an estimated net worth of $52.4 Million. This is based on reported shares across multiple companies, which include ImmunoGen, Inc., FATE THERAPEUTICS INC, LogicBio Therapeutics, Inc., Akebia Therapeutics, Inc., and KERYX BIOPHARMACEUTICALS INC.
SEC CIK
Mark J Enyedy's CIK is 0001586965
Past Insider Trading and Trends
2023 was Mark J Enyedy's most active year for acquiring shares with 9 total transactions. Mark J Enyedy's most active month to acquire stocks was the month of May. 2023 was Mark J Enyedy's most active year for disposing of shares, totalling 11 transactions. Mark J Enyedy's most active month to dispose stocks was the month of July. 2018 saw Mark J Enyedy paying a total of $11,715,000.00 for 1,198,688 shares, this is the most they've acquired in one year. In 2023 Mark J Enyedy cashed out on 6,126,929 shares for a total of $51,144,787.97, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ImmunoGen, Inc. (IMGN) Snapshot price: $29.59
CHIEF EXECUTIVE OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -584.40K |
—
|
—
|
0
|
Feb 12
| |||
Form 4
| +5.63% | 31.13K |
$29.28 | -$588,732.96 | 584.4K |
Scheduled
|
Feb 2 - Feb 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +25.33% | 111.82K |
$10.92 | -$36,072,131.72 | 553.27K |
Aug 2 - Aug 4
| |||
Form 4
| +1.20% | 5.24K |
$4.05 | $21,226.05 | 441.45K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20 - Nov 14
| |||
Form 4
| +0.77% | 3.34K |
$3.83 | $12,783.15 | 436.21K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
| +0.90% | 3.85K |
$5.52 | $21,246.48 | 432.87K |
Jun 30
| |||
Form 4
| -2.28% | -10.00K |
—
|
—
| 429.02K |
Dec 22 - Feb 5
| |||
Form 4
| +1.21% | 5.24K |
$3.91 | $20,492.31 | 439.02K |
Jun 30
| |||
Form 4
| -11.29% | -55.22K |
$4.99 | -$275,557.78 | 433.78K |
Scheduled
|
Feb 24
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
| +1.08% | 5.23K |
$1.84 | $9,623.20 | 489K |
Jul 1
| |||
Form 4
| -9.55% | -51.07K |
$5.60 | -$285,992.00 | 483.77K |
Scheduled
|
Feb 22
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| +0.46% | 2.46K |
$4.08 | $10,016.40 | 534.84K |
Jan 3
| |||
Form 4
| -11.28% | -67.72K |
$10.87 | -$736,083.79 | 532.38K |
Scheduled
|
Feb 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
| +499.50% | 500K |
$2.47 | $1,235,000.00 | 600.1K |
Feb 21
| |||
Form 4
| +33.29% | 25K |
$1.83 | $45,737.50 | 100.1K |
Nov 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FATE THERAPEUTICS INC (FATE) Snapshot price: $5.6211
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LogicBio Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.92K |
—
|
—
|
0
|
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
∞
| 2.92K |
—
|
—
| 2.92K |
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akebia Therapeutics, Inc. (AKBA) Snapshot price: $1.65
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +78.54% | 13.7K |
—
|
—
| 31.14K |
Jun 5
| |||
Form 4
| +366.02% | 13.7K |
—
|
—
| 17.44K |
Jun 6
| |||
Form 4
|
∞
| 3.74K |
—
|
—
| 3.74K |
Dec 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KERYX BIOPHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -10.00K |
—
|
—
|
0
|
Dec 12
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||